{"abstract": "The pharmaceutical giants GlaxoSmithKline and Pfizer said they would form a specialty company to research, develop and market treatments for H.I.V.", "web_url": "https://www.nytimes.com/2009/04/17/business/17drug.html", "snippet": "The pharmaceutical giants GlaxoSmithKline and Pfizer said they would form a specialty company to research, develop and market treatments for H.I.V.", "lead_paragraph": "Hoping to challenge Gilead Sciences, the leader in H.I.V. drugs, the pharmaceutical giants GlaxoSmithKline and Pfizer said Thursday that they would form a specialty company to research, develop and market treatments for H.I.V., the virus that causes AIDS. ", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [], "headline": {"main": "Glaxo and Pfizer Join Forces to Develop and Market H.I.V. Drugs", "kicker": null, "content_kicker": null, "print_headline": "Glaxo and Pfizer Join Forces to Develop and Market H.I.V. Drugs", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "GlaxoSmithKline PLC", "rank": 1, "major": "N"}, {"name": "subject", "value": "Medicine and Health", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Acquired Immune Deficiency Syndrome", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 5, "major": "N"}], "pub_date": "2009-04-16T18:00:34+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Natasha Singer", "person": [{"firstname": "Natasha", "middlename": null, "lastname": "Singer", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/54388f8b-ca16-5e0c-b49a-135b3d3e4342", "word_count": 598, "uri": "nyt://article/54388f8b-ca16-5e0c-b49a-135b3d3e4342"}